(globalThis.TURBOPACK||(globalThis.TURBOPACK=[])).push(["object"==typeof document?document.currentScript:void 0,71689,e=>{"use strict";let t=(0,e.i(75254).default)("arrow-left",[["path",{d:"m12 19-7-7 7-7",key:"1l729n"}],["path",{d:"M19 12H5",key:"x3x0zl"}]]);e.s(["ArrowLeft",()=>t],71689)},23385,e=>{"use strict";let t=(0,e.i(75254).default)("brain-circuit",[["path",{d:"M12 5a3 3 0 1 0-5.997.125 4 4 0 0 0-2.526 5.77 4 4 0 0 0 .556 6.588A4 4 0 1 0 12 18Z",key:"l5xja"}],["path",{d:"M9 13a4.5 4.5 0 0 0 3-4",key:"10igwf"}],["path",{d:"M6.003 5.125A3 3 0 0 0 6.401 6.5",key:"105sqy"}],["path",{d:"M3.477 10.896a4 4 0 0 1 .585-.396",key:"ql3yin"}],["path",{d:"M6 18a4 4 0 0 1-1.967-.516",key:"2e4loj"}],["path",{d:"M12 13h4",key:"1ku699"}],["path",{d:"M12 18h6a2 2 0 0 1 2 2v1",key:"105ag5"}],["path",{d:"M12 8h8",key:"1lhi5i"}],["path",{d:"M16 8V5a2 2 0 0 1 2-2",key:"u6izg6"}],["circle",{cx:"16",cy:"13",r:".5",key:"ry7gng"}],["circle",{cx:"18",cy:"3",r:".5",key:"1aiba7"}],["circle",{cx:"20",cy:"21",r:".5",key:"yhc1fs"}],["circle",{cx:"20",cy:"8",r:".5",key:"1e43v0"}]]);e.s(["BrainCircuit",()=>t],23385)},72747,e=>{"use strict";let t=(0,e.i(75254).default)("heart-handshake",[["path",{d:"M19.414 14.414C21 12.828 22 11.5 22 9.5a5.5 5.5 0 0 0-9.591-3.676.6.6 0 0 1-.818.001A5.5 5.5 0 0 0 2 9.5c0 2.3 1.5 4 3 5.5l5.535 5.362a2 2 0 0 0 2.879.052 2.12 2.12 0 0 0-.004-3 2.124 2.124 0 1 0 3-3 2.124 2.124 0 0 0 3.004 0 2 2 0 0 0 0-2.828l-1.881-1.882a2.41 2.41 0 0 0-3.409 0l-1.71 1.71a2 2 0 0 1-2.828 0 2 2 0 0 1 0-2.828l2.823-2.762",key:"17lmqv"}]]);e.s(["HeartHandshake",()=>t],72747)},21971,e=>{"use strict";var t=e.i(43476),a=e.i(57688),i=e.i(22016),s=e.i(46932),r=e.i(71689),n=e.i(38982),l=e.i(12426),c=e.i(25652),o=e.i(72520),d=e.i(72747),h=e.i(23385),m=e.i(20278),x=e.i(95135);let u=(0,e.i(75254).default)("microscope",[["path",{d:"M6 18h8",key:"1borvv"}],["path",{d:"M3 22h18",key:"8prr45"}],["path",{d:"M14 22a7 7 0 1 0 0-14h-1",key:"1jwaiy"}],["path",{d:"M9 14h2",key:"197e7h"}],["path",{d:"M9 12a2 2 0 0 1-2-2V6h6v4a2 2 0 0 1-2 2Z",key:"1bmzmy"}],["path",{d:"M12 6V3a1 1 0 0 0-1-1H9a1 1 0 0 0-1 1v3",key:"1drr47"}]]);var p=e.i(19455);let g=[{icon:c.TrendingUp,title:"High Alpha Potential",description:"Early-stage biotech offers the potential for exponential returns upon successful clinical trials and market approval."},{icon:d.HeartHandshake,title:"Solving Unmet Needs",description:"We target diseases with limited treatment options, creating immense value for patients and commanding strong market positioning."},{icon:h.BrainCircuit,title:"IP as a Core Asset",description:"Our investments are secured by robust intellectual property portfolios, creating a defensible moat."}],y=[{icon:x.TestTube2,title:"Novel Drug Discovery",description:"Backing first-in-class molecules and therapeutic approaches that fundamentally change treatment paradigms."},{icon:u,title:"Advanced Diagnostics",description:"Funding technologies that enable earlier and more accurate disease detection, unlocking better patient outcomes."},{icon:n.FlaskConical,title:"Process Innovation",description:"Investing in manufacturing and discovery platforms (e.g., AI-driven drug discovery) that accelerate the R&D lifecycle."}];function f(){return(0,t.jsxs)("div",{className:"bg-white text-neutral-800 font-serif",children:[(0,t.jsxs)("header",{className:"relative h-screen w-full",children:[(0,t.jsx)(a.default,{src:"https://images.unsplash.com/photo-1532187863486-abf9dbad1b69?q=80&w=2070",alt:"Pharmaceutical Lab",fill:!0,className:"object-cover",priority:!0,"data-ai-hint":"science lab"}),(0,t.jsx)("div",{className:"absolute inset-0 bg-gradient-to-t from-black/80 to-transparent"}),(0,t.jsx)("div",{className:"absolute bottom-0 left-0 right-0 p-12 text-white",children:(0,t.jsxs)(s.motion.div,{initial:{opacity:0,y:20},animate:{opacity:1,y:0},transition:{duration:.8},children:[(0,t.jsx)("h1",{className:"text-5xl md:text-7xl font-bold leading-tight",children:"The Science of Tomorrow"}),(0,t.jsx)("p",{className:"mt-4 max-w-2xl text-lg text-neutral-200",children:"Our investment thesis for early-stage biotech, focusing on novel drug discovery, advanced diagnostics, and process innovation."})]})})]}),(0,t.jsx)("main",{className:"py-24",children:(0,t.jsxs)("div",{className:"container mx-auto max-w-5xl px-6",children:[(0,t.jsxs)("div",{className:"mb-16 text-center",children:[(0,t.jsxs)(i.default,{href:"/healthcare",className:"text-sm uppercase tracking-widest text-neutral-500 hover:text-black transition-colors mb-4 inline-flex items-center gap-2",children:[(0,t.jsx)(r.ArrowLeft,{size:16})," Back to Healthcare"]}),(0,t.jsx)("h2",{className:"text-4xl font-bold mt-2",children:"Thesis: Next-Generation Medicine"})]}),(0,t.jsxs)("div",{className:"prose prose-lg lg:prose-xl max-w-none mx-auto text-neutral-600",children:[(0,t.jsx)("p",{className:"lead",children:"The future of human health will be written in the language of molecules, genes, and data. GrowShare Capitalâ€™s Pharmaceutical Innovations thesis is dedicated to funding the companies that are writing this future. We invest at the intersection of deep science and market opportunity, backing the breakthroughs that will define the next generation of medicine."}),(0,t.jsx)("blockquote",{className:"border-l-4 border-primary bg-primary/5 p-6 rounded-r-lg",children:"We invest in the science that pushes boundaries, the technology that redefines possibility, and the teams that have the audacity to pursue both."})]}),(0,t.jsx)("hr",{className:"my-20"}),(0,t.jsxs)("section",{className:"mb-20",children:[(0,t.jsx)("h3",{className:"text-3xl font-bold text-center mb-12",children:"The Case for Early-Stage Biotech"}),(0,t.jsx)("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-8",children:g.map((e,a)=>(0,t.jsxs)("div",{className:"text-center",children:[(0,t.jsx)("div",{className:"mx-auto w-16 h-16 rounded-full bg-primary/10 flex items-center justify-center mb-4",children:(0,t.jsx)(e.icon,{className:"w-8 h-8 text-primary"})}),(0,t.jsx)("h4",{className:"font-bold text-lg mb-2",children:e.title}),(0,t.jsx)("p",{className:"text-sm text-neutral-500",children:e.description})]},a))})]}),(0,t.jsx)("hr",{className:"my-20"}),(0,t.jsxs)("section",{className:"bg-neutral-900 text-white -mx-6 px-6 py-20 rounded-2xl",children:[(0,t.jsx)("h3",{className:"text-3xl font-bold text-center mb-12",children:"Core Investment Areas"}),(0,t.jsx)("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-8",children:y.map((e,a)=>(0,t.jsxs)("div",{className:"p-6 border border-white/20 rounded-lg",children:[(0,t.jsx)(e.icon,{className:"w-8 h-8 text-primary mb-4"}),(0,t.jsx)("h4",{className:"font-bold text-lg mb-2",children:e.title}),(0,t.jsx)("p",{className:"text-sm text-neutral-400",children:e.description})]},a))})]}),(0,t.jsx)("hr",{className:"my-20"}),(0,t.jsxs)("section",{className:"text-center",children:[(0,t.jsx)(m.Target,{className:"w-12 h-12 text-primary mx-auto mb-4"}),(0,t.jsx)("h3",{className:"text-3xl font-bold mb-4",children:"Our Ideal Partner"}),(0,t.jsx)("p",{className:"text-neutral-600 max-w-3xl mx-auto mb-8",children:"We look for Pre-Seed to Series B companies with a strong, patent-defensible scientific foundation, a leadership team with a proven track record in both research and commercialization, and a clear, capital-efficient path through clinical development."})]}),(0,t.jsx)("hr",{className:"my-20"}),(0,t.jsxs)("section",{className:"text-center bg-primary/5 p-12 rounded-2xl",children:[(0,t.jsx)(l.DollarSign,{className:"w-12 h-12 text-primary mx-auto mb-4"}),(0,t.jsx)("h3",{className:"text-3xl font-bold mb-4",children:"Shape the Future of Medicine"}),(0,t.jsx)("p",{className:"text-neutral-600 max-w-3xl mx-auto mb-8",children:"If your company is pioneering the next therapeutic breakthrough, we want to hear from you. Connect with our life sciences team to discuss how we can help you accelerate your mission."}),(0,t.jsx)(p.Button,{asChild:!0,size:"lg",children:(0,t.jsxs)(i.default,{href:"/contact?subject=Pharmaceutical Innovations Inquiry",children:["Connect With Our Team ",(0,t.jsx)(o.ArrowRight,{className:"ml-2 w-4 h-4"})]})})]})]})})]})}e.s(["default",()=>f],21971)}]);